The characterisation of subjective cognitive decline

dc.contributor.authorJessen, Frank
dc.contributor.authorAmariglio, Rebecca E.
dc.contributor.authorBuckley, Rachel F.
dc.contributor.authorvan der Flier, Wiesje M.
dc.contributor.authorHan, Ying
dc.contributor.authorMolinuevo, José Luis
dc.contributor.authorRabin, Laura
dc.contributor.authorRentz, Dorene M.
dc.contributor.authorRodriguez-Gomez, Octavio
dc.contributor.authorSaykin, Andrew J.
dc.contributor.authorSikkes, Sietske A.M.
dc.contributor.authorSmart, Colette M.
dc.contributor.authorWolfsgruber, Steffen
dc.contributor.authorWagner, Michael
dc.contributor.departmentMedical and Molecular Genetics, School of Medicineen_US
dc.date.accessioned2022-07-18T17:02:22Z
dc.date.available2022-07-18T17:02:22Z
dc.date.issued2020-03
dc.description.abstractA growing awareness about brain health and Alzheimer's disease in the general population is leading to an increasing number of cognitively unimpaired individuals, who are concerned that they have reduced cognitive function, to approach the medical system for help. The term subjective cognitive decline (SCD) was conceived in 2014 to describe this condition. Epidemiological data provide evidence that the risk for mild cognitive impairment and dementia is increased in individuals with SCD. However, the majority of individuals with SCD will not show progressive cognitive decline. An individually tailored diagnostic process might be reasonable to identify or exclude underlying medical conditions in an individual with SCD who actively seeks medical help. An increasing number of studies are investigating the link between SCD and the very early stages of Alzheimer's disease and other neurodegenerative diseases.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationJessen F, Amariglio RE, Buckley RF, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19(3):271-278. doi:10.1016/S1474-4422(19)30368-0en_US
dc.identifier.urihttps://hdl.handle.net/1805/29610
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/S1474-4422(19)30368-0en_US
dc.relation.journalThe Lancet Neurologyen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectAlzheimer Diseaseen_US
dc.subjectCognitive Dysfunctionen_US
dc.subjectNeuropsychological Testsen_US
dc.subjectCognitionen_US
dc.titleThe characterisation of subjective cognitive declineen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms-1566559.pdf
Size:
672.48 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: